Purpose/Objective: We are developing a novel platform technology that utilizes a chimeric transposase to direct integration into specific sites in the host DNA. Thus, this technology minimizes non-specific integration that may result in insertional mutagenesis which can induce cancer and may disrupt genes that affect the fitness of the organism unrelated to cancer.